Endovascular Engineering, Inc. ("E2") has secured $42 million in an oversubscribed Series B financing to advance its next generation clot removal technology platform for venous thromboembolism (VTE).

In the United States alone, 104 million people are at risk of cardiovascular disease, and in a study of those that experienced a heart attack at age 50 or younger, half were not previously seen as ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health conditions.

Now, research from my lab and others suggests that GLP-1 drugs ... risk of blood clotting as well as deep vein thrombosis and pulmonary embolism. One puzzling finding in our study is the reduced ...

Mechanical thrombectomy is effective and safe for treating pulmonary embolism (PE). Although the Tendvia mechanical thrombectomy system has been validated in pigs, further evidence supporting its ...

Acute pulmonary embolism is rare during childhood and adolescence. The high pulmonary embolism-related fatality among ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Mechanical thrombectomy is effective and safe for treating pulmonary embolism (PE).

"I am incredibly excited to be involved in this study as it represents a significant milestone in the forward trajectory of pulmonary embolism treatment." The QUADRA-PE study is a multi-center, ...

A parallel communication regarding these factors in dogs with experimentally produced pulmonary embolism will be reported elsewhere. 6 All 11 patients in this study were treated on the medical or ...